These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 25445601)

  • 1. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
    Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RITA inhibits growth of human hepatocellular carcinoma through induction of apoptosis.
    Wang H; Chen G; Wang H; Liu C
    Oncol Res; 2013; 20(10):437-45. PubMed ID: 24308154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
    Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
    PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX3 directly interacts with intracellular domain of Notch1 and suppresses Notch signaling in hepatocellular carcinoma cells.
    Gao J; Chen Y; Wu KC; Liu J; Zhao YQ; Pan YL; Du R; Zheng GR; Xiong YM; Xu HL; Fan DM
    Exp Cell Res; 2010 Jan; 316(2):149-57. PubMed ID: 19800882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
    Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
    Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
    Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
    Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.
    Cheng Q; Cao X; Yuan F; Li G; Tong T
    Biochem Biophys Res Commun; 2014 Jun; 448(3):248-54. PubMed ID: 24792179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7.
    Chen J; Wang H; Wang J; Huang S; Zhang W
    Cancer Cell Int; 2015; 15():111. PubMed ID: 26617467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function analysis of RBP-J-interacting and tubulin-associated (RITA) reveals regions critical for repression of Notch target genes.
    Tabaja N; Yuan Z; Oswald F; Kovall RA
    J Biol Chem; 2017 Jun; 292(25):10549-10563. PubMed ID: 28487372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
    Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
    J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation.
    Lee TK; Man K; Ho JW; Sun CK; Ng KT; Wang XH; Wong YC; Ng IO; Xu R; Fan ST
    Carcinogenesis; 2004 Dec; 25(12):2397-405. PubMed ID: 15297371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
    Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
    Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE
    Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma.
    Huang HL; Zheng WL; Zhao R; Zhang B; Ma WL
    Oncol Rep; 2010 Sep; 24(3):715-20. PubMed ID: 20664978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.